If Cannabis Is Reclassified, What Will Happen to the Marketplace? – Diagnosing Health Care
Podcast - DEA Plants the Seed for Rescheduling Marijuana: What's Next?
The Presumption of Innocence Podcast: Special Edition | Episode 36 - Rolling Change: The DEA Turns Over a New Leaf on Marijuana Scheduling
A history of the decline and rise of the marijuana empire
Podcast: Non-binding Guidance: FDA’s Regulation of Products Containing CBD
Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana. This week, the big news is coming out of Virginia, where there will not be a retail cannabis market. Meanwhile, the...more
Welcome back to the buzz, our monthly cannabis news and policy update. Your at-a-glance source for regulatory developments, agency announcements, and trends impacting the cannabis industry. In this edition of the buzz,...more
The story of federal psychedelic policy over the last few years has been, in many ways, the story of two tracks running parallel — and occasionally colliding. On one track: a growing body of clinical research, bipartisan...more
The United States Department of Justice (DOJ) and the Drug Enforcement Administration (DEA) recently issued a press release announcing a final order that significantly impacts the federal treatment of marijuana under the...more
Those of you who have been following along with our series on marijuana rescheduling know that on April 22, 2026, the DEA issued its long-awaited final order moving certain marijuana products — specifically state-licensed...more
Updated December 18, 2025: Today, President Donald Trump signed an executive order directing federal agencies to begin the process of reclassifying marijuana from Schedule I to Schedule III under the Controlled Substances Act...more
Apr 20, 2026 On the morning of Saturday, April 18, 2026, President Donald Trump signed an executive order (EO), Accelerating Medical Treatments For Serious Mental Illness, directing federal agencies to begin the processes of...more
Federal cannabis law has never tracked cleanly with the illicit, and then state-legal markets that grew up around it. For decades, marijuana was listed on Schedule I under the Controlled Substances Act, while states built...more
As previewed in our recent blog posts, the DEA application portal for expedited registration of medical marijuana dispensaries is now open and businesses are currently able to submit applications....more
Feds in historic move re-classify medical marijuana as a less dangerous drug, ease tax burden on state medical marijuana licensees, establish expedited federal registration process and announce a June 2026 hearing to...more
The DEA issued a final order on Apr. 22nd, moving certain marijuana classifications from Schedule I to Schedule III of the Controlled Substances Act (CSA). ...more
The U.S. Department of Justice issued an Order on April 22, 2026 immediately placing all FDA-approved marijuana products and marijuana products regulated by a state medical marijuana license in Schedule III of the Controlled...more
For nearly three decades, the American cannabis industry has existed in a condition that can only be described as legally schizophrenic. States have licensed, taxed, regulated, insured, zoned, audited, and in some cases...more
New Order and Anticipated Regulation Have Significant Workplace Implications - With the stroke of a pen, Acting Attorney General Todd Blanche issued a new “final order” on April 23, 2026, that reclassifies FDA-approved...more
On December 18, 2025, President Donald Trump signed Executive Order 14370, directing the Attorney General to expedite the long-stalled rulemaking process to reschedule marijuana from Schedule I to Schedule III under the...more
The Trump administration’s interest in psychedelics as medicine has continued to come into focus over the past several weeks, with two developments suggesting that momentum at the federal level continues to grow....more
Few industries in recent American history have climbed so fast or stand to fall so hard. The hemp-derived THC beverage industry went from virtually nonexistent in 2018 to a market worth an estimated $1.375 billion in annual...more
Since President Biden announced the initiation of proceedings to reschedule marijuana and President Trump issued an executive order directing the attorney general to do so as expeditiously as possible, industry stakeholders...more
As discussions around federal cannabis rescheduling gain traction, employers across industries are asking how a change in cannabis’s federal status could affect workplace policies, employee protections, and compliance...more
Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana. This week, we have an update on the Florida situation. We check in on Ohio, where some recent legislative changes are...more
President Trump recently signed Executive Order “Increasing Medical Marijuana and Cannabidiol Research,” published on December 18, 2025. This important measure directed federal agencies to reclassify cannabis from Schedule 1...more
Employers are facing one of the most consequential shifts on workplace drug policy in recent memory. On December 18, 2025, President Trump signed an Executive Order that reclassifies marijuana from a Schedule I to a Schedule...more
Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana. This week, lawmakers considered blocking the administration’s move to reschedule cannabis. Virginia began the move to...more